
Inspires a passion for knowledge and growth.
Always approachable and supportive.
Makes learning feel rewarding and fun.
Always positive and enthusiastic in class.
Always fair, kind, and deeply insightful.
Dr. Matthew Snelson is a National Heart Foundation Postdoctoral Fellow in the Hypertension Research Laboratory, School of Biological Sciences, Faculty of Science at Monash University, a position he has held since 2023. An advanced Accredited Practicing Dietitian, he previously served as Research Fellow in the Department of Diabetes at Monash University from 2019. Snelson earned his PhD from Monash University in 2019, with a thesis entitled "The effects of dietary advanced glycation endproducts on gut homeostasis and chronic kidney disease." His academic background includes a Postgraduate Diploma in Biotechnology from Swinburne University in 2014, a Bachelor of Health Sciences (Honours) from Curtin University in 2012, a Postgraduate Diploma in Dietetics from Curtin University in 2009, and a Bachelor of Science (Nutrition) from Curtin University between 2006 and 2008. Earlier in his career, he worked as a Clinical Dietitian at Royal Perth Hospital from 2010 to 2012, and held research roles at Curtin University.
Snelson's research centers on the interplay between diet, gut microbiota, intestinal permeability, and conditions such as hypertension, cardiovascular disease, diabetes complications, and chronic kidney disease. His studies examine how prebiotic fiber, resistant starch, and dietary advanced glycation end products influence gut microbial ecology, barrier function, systemic inflammation, and organ damage. He has published over 35 peer-reviewed articles, with standout works including "Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease" (Circulation, 2020), "Dietary advanced glycation end products: digestion, metabolism and modulation of gut microbial ecology" (Nutrients, 2019), "Processed foods drive intestinal barrier permeability and microvascular diseases" (Science Advances, 2021), and "Gut microbiome, prebiotics, intestinal permeability and diabetes complications" (Best Practice & Research Clinical Endocrinology & Metabolism, 2021). Snelson has garnered 19 national and international awards, such as the 2024 Faculty of Science Research Excellence by an Early Career Researcher Award, multiple best presentation prizes from the Nutrition Society of Australia and Australasian Diabetes Congress, and travel grants from the Australian New Zealand Society of Nephrology and European Association for the Study of Diabetes. He formerly served as president of the Australasian Human Microbiome Research Network and has delivered presentations at numerous conferences.